A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.
Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market.
Market Analysis and Insights: Global Central Nervous System (CNS) Therapeutic Market
The global Central Nervous System (CNS) Therapeutic market size is projected to reach US$ 76830 million by 2026, from US$ 74150 million in 2020, at a CAGR of 3.3%% during 2021-2026.
Global Central Nervous System (CNS) Therapeutic Scope and Market Size
Central Nervous System (CNS) Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
Takeda
Central Nervous System (CNS) Therapeutic Breakdown Data by Type
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Central Nervous System (CNS) Therapeutic Breakdown Data by Application
Clinical Application
Others
Advancements in diagnostics, therapeutics and drug discovery techniques will further trigger the growth of central nervous system therapeutic market.
Market Analysis and Insights: Global Central Nervous System (CNS) Therapeutic Market
The global Central Nervous System (CNS) Therapeutic market size is projected to reach US$ 76830 million by 2026, from US$ 74150 million in 2020, at a CAGR of 3.3%% during 2021-2026.
Global Central Nervous System (CNS) Therapeutic Scope and Market Size
Central Nervous System (CNS) Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Central Nervous System (CNS) Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Pfizer
Biogen
Johnson & Johnson
Eli Lilly
Otsuka America Pharmaceutical
Merck
Astrazeneca
Novartis
Teva Pharmaceutical Industries
Takeda
Central Nervous System (CNS) Therapeutic Breakdown Data by Type
Neurovascular
Trauma
Mental Health
Degenerative Disorder
Infections
Cancer
Central Nervous System (CNS) Therapeutic Breakdown Data by Application
Clinical Application
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurovascular
1.4.3 Trauma
1.4.4 Mental Health
1.4.5 Degenerative Disorder
1.4.6 Infections
1.4.7 Cancer
1.5 Market by Application
1.5.1 Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Clinical Application
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2015-2026)
2.2 Global Central Nervous System (CNS) Therapeutic Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Central Nervous System (CNS) Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Central Nervous System (CNS) Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Market Size
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.2.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2019
3.3 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.4 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.5 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
6.2 Central Nervous System (CNS) Therapeutic Key Players in North America (2019-2020)
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
7.2 Central Nervous System (CNS) Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
8.2 Central Nervous System (CNS) Therapeutic Key Players in China (2019-2020)
8.3 China Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
8.4 China Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
9.2 Central Nervous System (CNS) Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
9.4 Japan Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
10.2 Central Nervous System (CNS) Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
11.2 Central Nervous System (CNS) Therapeutic Key Players in India (2019-2020)
11.3 India Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
11.4 India Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
12.2 Central Nervous System (CNS) Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
13.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Biogen
13.2.1 Biogen Company Details
13.2.2 Biogen Business Overview
13.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
13.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.2.5 Biogen Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
13.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
13.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Otsuka America Pharmaceutical
13.5.1 Otsuka America Pharmaceutical Company Details
13.5.2 Otsuka America Pharmaceutical Business Overview
13.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
13.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.5.5 Otsuka America Pharmaceutical Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
13.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Astrazeneca
13.7.1 Astrazeneca Company Details
13.7.2 Astrazeneca Business Overview
13.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
13.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.7.5 Astrazeneca Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
13.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Takeda
13.10.1 Takeda Company Details
13.10.2 Takeda Business Overview
13.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
13.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.10.5 Takeda Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurovascular
1.4.3 Trauma
1.4.4 Mental Health
1.4.5 Degenerative Disorder
1.4.6 Infections
1.4.7 Cancer
1.5 Market by Application
1.5.1 Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Clinical Application
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2015-2026)
2.2 Global Central Nervous System (CNS) Therapeutic Growth Trends by Regions
2.2.1 Central Nervous System (CNS) Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Central Nervous System (CNS) Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Central Nervous System (CNS) Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Market Size
3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio
3.2.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2019
3.3 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served
3.4 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service
3.5 Date of Enter into Central Nervous System (CNS) Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
6.2 Central Nervous System (CNS) Therapeutic Key Players in North America (2019-2020)
6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
7.2 Central Nervous System (CNS) Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
8.2 Central Nervous System (CNS) Therapeutic Key Players in China (2019-2020)
8.3 China Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
8.4 China Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
9.2 Central Nervous System (CNS) Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
9.4 Japan Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
10.2 Central Nervous System (CNS) Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
11.2 Central Nervous System (CNS) Therapeutic Key Players in India (2019-2020)
11.3 India Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
11.4 India Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Central Nervous System (CNS) Therapeutic Market Size (2015-2020)
12.2 Central Nervous System (CNS) Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Central Nervous System (CNS) Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction
13.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Biogen
13.2.1 Biogen Company Details
13.2.2 Biogen Business Overview
13.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction
13.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.2.5 Biogen Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction
13.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction
13.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Otsuka America Pharmaceutical
13.5.1 Otsuka America Pharmaceutical Company Details
13.5.2 Otsuka America Pharmaceutical Business Overview
13.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction
13.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.5.5 Otsuka America Pharmaceutical Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction
13.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Astrazeneca
13.7.1 Astrazeneca Company Details
13.7.2 Astrazeneca Business Overview
13.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction
13.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.7.5 Astrazeneca Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction
13.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Teva Pharmaceutical Industries
13.9.1 Teva Pharmaceutical Industries Company Details
13.9.2 Teva Pharmaceutical Industries Business Overview
13.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction
13.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.9.5 Teva Pharmaceutical Industries Recent Development
13.10 Takeda
13.10.1 Takeda Company Details
13.10.2 Takeda Business Overview
13.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction
13.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2015-2020)
13.10.5 Takeda Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
